Cheryl Cohen - 05 Jul 2022 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Director
Signature
/s/ Brian G. Drazba, as attorney in fact
Issuer symbol
MEIP
Transactions as of
05 Jul 2022
Net transactions value
$0
Form type
4
Filing time
07 Jul 2022, 16:25:46 UTC
Previous filing
17 Jun 2022
Next filing
15 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +87,500 $0.000000 87,500 05 Jul 2022 Common Stock 87,500 $0.5400 Direct F1
holding MEIP Stock Option (Right to Buy) 50,000 05 Jul 2022 Common Stock 50,000 $2.95 Direct F2
holding MEIP Stock Option (Right to Buy) 50,000 05 Jul 2022 Common Stock 50,000 $3.49 Direct F2
holding MEIP Stock Option (Right to Buy) 30,000 05 Jul 2022 Common Stock 30,000 $1.71 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in equal monthly installments over twelve months.
F2 All of such options are presently exercisable.
F3 20,000 options will vest in equal monthly installments over thirty-six months from April 10, 2020 and 10,000 options shall vest in equal monthly installments over twelve months from April 10, 2020.